BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 18160420)

  • 1. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
    Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
    Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
    Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization.
    Chen M; Zhang W; Xu W; Zhang F; Xiong S
    Mol Immunol; 2011 Jul; 48(12-13):1532-9. PubMed ID: 21592581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
    Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
    Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
    Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
    Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG
    Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
    Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
    J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor expression in lupus peripheral blood mononuclear cells.
    Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Kimura H; Ishibashi H; Eguchi K
    J Rheumatol; 2007 Mar; 34(3):493-500. PubMed ID: 17295441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
    Lindau D; Rönnefarth V; Erbacher A; Rammensee HG; Decker P
    Eur J Immunol; 2011 Mar; 41(3):669-81. PubMed ID: 21287547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
    Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
    Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.
    Stoehr AD; Schoen CT; Mertes MM; Eiglmeier S; Holecska V; Lorenz AK; Schommartz T; Schoen AL; Hess C; Winkler A; Wardemann H; Ehlers M
    J Immunol; 2011 Sep; 187(6):2953-65. PubMed ID: 21859955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.